Healthcare WHO agrees global effort to eliminate viral hepatitis by 203... All of the WHO's 194 member states have voted to eliminate viral hepatitis by 2030 as part of a global strategy.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.